Rotational defects of the lower limb are frequently encountered and often underestimated. In fact, many symptoms in the lower joint can be related to rotational alteration in the lower leg. These problems are often more visible in the knee joint because they reflect the rotational problems of proximal and distal femur and tibia, respectively. The extensor apparatus, due to the fact that it interacts with both bones, is the more affected joint. Many authors have demonstrated that femoral anteversion increases stress on the patello-femoral joint due to excessive lateralisation of the patella. In the same manner, distal femur internal rotation increases the stress due to altered tracking of the patella during ROM.

Valgus knee places stress on the patello-femoral joint, increasing the Q angle and determining a retraction of the lateral structure that causes stress on the lateral patellar face and altered patellar scratch during ROM. External tibial rotation also has been documented to increase the Q angle and patellar tilt, causing excessive stress on the patello-femoral joint. Valgus pronation of the foot, increasing the valgus stress on the knee, can contribute to patello-femoral symptoms, increasing the muscle imbalance at this level.

These documented alterations contribute together with other anatomical abnormalities, such as trochlear dysplasia or muscle hypoplasia, in creating the high variability of patello-femoral symptoms that are observed. Rotational deformity of the lower leg therefore represents a frequently encountered pathological condition that must be taken into account when treating patello-femoral symptoms.

A tissue engineering-based approach has become a possible solution for the treatment of chondral lesions. Actually, autologous chondrocytes seeded on biodegradable scaffolds for cell proliferation were successfully developed. However, these techniques promote cartilaginous but not bony regeneration. Therefore a new experimental approach involving mesenchymal stem cells (MSC) has been introduced.

A 31-year-old man affected by massive osteonecrosis of the right femoral head was selected to begin this study. The MSC were isolated from the bone marrow harvested from the patient’s iliac crest. After a 3-week monolayer expansion, cells were seeded and cultured onto hyaluronan-based three-dimensional scaffolds and DBM spongy chips, used to regenerate the cartilaginous and the bony portion, respectively. After a 2-week cultivation, constructs were implanted inside the osteochondral defect using the transtrochanteric approach under arthroscopic control. The patient underwent clinical, X-ray and MRI control during the first 6 months after operation.

Pluripotent MSC may be a promising strategy for osteochondral defect reconstruction due to their capacity to differentiate in vivo along chondrocytic and osteoblastic lineages. This ability, combined with two different kinds of three-dimensional scaffolds, permits simultaneous bone and cartilage tissue regeneration. The preliminary results are encouraging but a more precise judgement of the effectiveness of this method requires longer follow-up.

Valgus deformity of the knee in relation to femoral dysplasia and post-traumatic varus deformity in relation to supracondylar fracture often needs to be corrected with varus or valgus distal femoral osteotomy. This procedure must be very precise to avoid compartimental overstress. However, in valgus knee the deformity is very often not only bi-planar but also tri-planar. In fact, the rotational defect of the distal femur can play an important role in determining the clinical symptoms and in altering the pathway of patello-femoral joint.

Therefore, correcting only the valgus deformity does not solve the clinical symptoms related to incorrect rotation of distal femur. The same problem is often encountered in distal femoral deformity in relation to supracondylar fracture. The bad alignment of the healed fracture is very often on the three planes and this fact has always to be taken into account during the pre-operative planning.

The pre-operative planning is fundamental and CT of the knee joint with reference to hip and ankle must be performed to evaluate the degree of rotational deformity that must be corrected. During surgery after the correction of valgus or varus deformity is fundamental to re-check the femur rotation, because the osteotomy automatically changes also the rotation of the distal femur. However, this correction may be insufficient to correct the rotation that can maintain clinical symptoms in the patello-femoral joint. If this is the case, an additional correction in external rotation is usually necessary to achieve an overall correction of distal femoral deformity.

In our opinion, the difficulties and accuracy necessary to correct this type of pathology are often underestimated.

Autologous chondrocyte transplantation has become a possible solution for the treatment of chondral knee lesions. In the last years matrix autologous chondrocyte transplantation procedures were developed by various scientists. We selected a biodegradable, hyaluronian-based biocompatible scaffold for cell proliferation. This nonwoven three-dimensional structure consists of a network of 20 – B5-thick fibers with interstices of variable sizes which constitute an optimal physical support to allow cell-cell contacts, cluster formation, and extracellular matrix deposition in order to create a bioengenerized cartilage Hyalograft C. The easy handling of Hyalograft C in open surgery has suggested us to investigate its possible use by an arthroscopic procedure.

Arthroscopic technique has been used from December 2000 in 88 cases. At December 2003 45 patients achieved at least 1 year follow up and 22 patients – 2 years follow up.

All the patients were clinically evaluated was analyzed according to the International Repair Cartilage Society score at 12 and 24 months. Returning back to sport was also recorded. We were able to obtain CT scans or MRI images for all patients at 6, 12 and 24 months of follow up.

No complications related to the implant and no serious adverse events were observed during the treatment and follow up period. The IKDC objective score improved after 12 months in all patients, showing a normal or nearly normal knee in 96,7% of patients. The mean IKDC subjective score obtained was 41,3 at baseline, 76.9 at the 12 months follow-up control, and 75,9 after 24 months. The worsening of IKDC score was noted in 1 of 22 patients analyzed at 12 and 24 months follow up.

A second look arthroscopy was performed in 11 patients at 12 months follow up and a complete healing of the defect and the excellent quality of regenerated cartilage was noted at macroscopic examination. The histological evaluation in 6 cases has demonstrated the hyaline type of new cartilage, although not completely mature.

This matrix autologous chondrocyte transplantation procedure avoids the use of periosteal flap, simplify the surgical procedure and permit to perform the arthroscopic implant. Thus, complications as hypertrophy or ossification of periosteal flap are avoided and the surgical morbidity and the recovery time for the patient are extremely reduced. The preliminary clinical and histological results are encouraging but the decree absolute on the efficiency of this method will be assessed at longer follow up.